Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

NCT05694884 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
75
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

ASLAN Pharmaceuticals